U.S. Consumers Received Just Under 3.8 Billion Robocalls in October 2025, According to YouMail Robocall Index
October 2025's Volume Lowest Since December, 2023
News
3 min read
Legal 500 US 2020 Highlights Cooley
26 Jun, 2020
Palo Alto – June 24, 2020 – The Legal 500 United States 2020 recognized 23 Cooley practice areas and recommended Cooley as a #1 firm for capital markets: equity offerings, venture capital and emerging companies and technology transactions. Fourteen attorneys were recognized as leading lawyers in their respective fields and firm chairman emeritus Stephen Neal and partner Michael Rhodes were singled out as leading trial lawyers. M&A co-chairs Barbara Borden and Jamie Leigh and capital markets co-chairs Charlie Kim and David Peinsipp were also recognized. Partners Ben Beerle, Kate Hillier, Siana Lowrey, David Navetta, Boris Segalis and Adriana Lofaro Wirtz were recognized as next generation lawyers. In total, 70 lawyers were recommended in The Legal 500 United States 2020 editorial. The following Cooley practices and lawyers were highlighted:
Recommended practice groups
Denotes tier 1 ranking
Hall of Fame
Next generation partners
Recommended Lawyers
About Cooley LLP Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has 1,100+ lawyers across 16 offices in the United States, Asia and Europe.
Capital markets: equity offerings
Cyber law (including privacy and data protection)
Fintech
General commercial disputes
Healthcare: life sciences
International arbitration
Land use/zoning
Leading trial lawyers
M&A: middle-market ($500m-999m)
Patents: litigation (full coverage)
Patents: prosecution (including re-examination and post-grant proceedings)
Private equity funds (including venture capital)
Real estate
Securities litigation: defense
Technology transactions
Telecoms and broadcast: regulatory
Telecoms and broadcast: transactional
Trade secrets (litigation and non-contentious matters)
Trademarks: litigation
Trademarks: non-contentious (including prosecution, portfolio management and licensing)
US taxes: contentious
US taxes: non-contentious
Venture capital and emerging companies
Leading lawyers
| Keith Berets | Technology transactions |
| Heidi Keefe | Patents: litigation (full coverage) |
| Charlie Kim | Capital markets: equity offerings |
| Alexander Lee | US taxes: non-contentious |
| Jamie Leigh | M&A: middle-market ($500m-999m) |
| David Peinsipp | Capital markets: equity offerings |
| Mark Tanoury | Venture capital and emerging companies |
| Barbara Borden | M&A: middle-market ($500m-999m) |
| John Crittenden | Trademarks: litigation |
| Barbara Kosacz | Healthcare: life sciences |
| Fred Muto | Venture capital and emerging companies |
| Stephen Neal | Leading trial lawyers |
| Michael Rhodes | Leading trial lawyers |
| Adam Ruttenberg | Technology transactions |
| Ben Beerle | M&A: middle-market ($500m-999m) |
| Kate Hillier | Healthcare: life sciences |
| Siana Lowrey | Capital markets: equity offerings |
| David Navetta | Cyber law (including data privacy and data protection) |
| Boris Segalis | Cyber law (including data privacy and data protection) |
| Adriana Lofaro Wirtz | US taxes: contentious |
| Michael Attanasio | General commercial disputes |
| Michael Basile | Telecoms and broadcast: regulatory Telecoms and broadcast: transactional |
| Mark Beckett | International arbitration |
| Laura Berezin | Healthcare: life sciences |
| Matthew Bartus | Venture capital and emerging companies |
| Philip Bowman | General commercial disputes |
| Matthew D. Brown | Media, technology and telecoms – Cyber law (including data privacy and data protection) |
| Alfred Browne | Fintech |
| Kay Chandler | Healthcare: life sciences |
| Adam Chase | Technology transactions |
| John Clendenin | Private equity funds (including venture capital) |
| William Corcoran | US taxes: non-contentious |
| John Dado | Private equity funds (including venture capital) |
| Joseph Drayton | General commercial disputes |
| Ivor Elrifi | Healthcare: life sciences Patents: prosecution (including re-examination and post-grant proceedings) |
| John Feore | Telecoms and broadcast: regulatory Telecoms and broadcast: transactional |
| Koji Fukumura | Securities litigation: defense |
| Adam Gershenson | Trade secrets (litigation and non-contentious matters) |
| Bobby Ghajar | Trademarks: litigation Trademarks: non-contentious (including prosecution, portfolio management and licensing) |
| Patrick Gibbs | Securities litigation: defense |
| Colleen Gillis | Land use/zoning |
| Shane Goudey | Private equity funds (including venture capital) |
| TJ Graham | Technology transactions |
| Jeff Greene | Trademarks: non-contentious (including prosecution, portfolio management and licensing) |
| Div Gupta | Capital markets: equity offerings |
| Lila Hope | Healthcare: life sciences |
| Jack Lavoie | Land use/zoning |
| Travis LeBlanc | Cyber law (including data privacy and data protection) |
| Alan Levine | General commercial disputes |
| Mike Lincoln | Venture capital and emerging companies |
| Mark Looney | Land use/zoning |
| Mika Reiner Mayer | Healthcare: life sciences Patents: prosecution (including re-examination and post-grant proceedings) |
| Robert McDowell | Telecoms and broadcast: regulatory Telecoms and broadcast: transactional |
| Kevin Mills | Telecoms and broadcast: transactional |
| Patrick Mitchell | Venture capital and emerging companies |
| Kathleen Pakenham | US taxes: contentious |
| Nicole Peppe | Private equity funds (including venture capital) |
| Marya Postner | Healthcare: life sciences |
| Jason Rademacher | Telecoms and broadcast: regulatory |
| Marc Recht | Healthcare: life sciences |
| Randy Sabett | Cyber law (including data privacy and data protection) |
| Ian Shapiro | Trade secrets (litigation and non-contentious matters) |
| Michael Sheetz | Trade secrets (litigation and non-contentious matters) |
| Jordan Silber | Private equity funds (including venture capital) |
| Stephen Smith | Patents: litigation (full coverage) |
| Marc Suskin | International arbitration |
| Rachel Thorn | International arbitration |
| Mark Weeks | Healthcare: life sciences |
| Henry Wendel | Telecoms and broadcast: regulatory Telecoms and broadcast: transactional |
| Dave Young | Venture capital and emerging companies |
